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‘I recall seeing a package to make quotes’ 




A large body of work has been dedicated to understanding and remedying the pathological 
processes that take place after spinal cord injury. Despite these efforts, treatment options are 
limited and patients with spinal cord injury are left with life-long disability.  
The work described in this thesis is part of an ongoing effort to learn about endogenous 
neural stem cells as potential targets for therapies aiming to repair the injured spinal cord.  
In paper I, we studied the effects of ablating the ependymal neural stem cell response to 
spinal cord injury, in order to understand their functional role in the injury response. We 
found that the ependymal cell contribution to the injury response keeps the injury from 
growing deeper and severing additional axonal tracts, as well as limits neuronal loss. These 
findings identify ependymal cells as an interesting target for intervention.  
In paper II, we discovered a latently accessible program for oligodendrogenesis in 
ependymal cells by analyzing their gene expression and chromatin accessibility patterns. We 
activated the oligodendrogenesis program using a combination of forced Olig2 expression 
and spinal cord injury. The activation of the oligodendrogenesis program leads to an 
increased production of ependymal-derived oligodendrocytes, enhances remyelination and 
supports conduction of nerve impulses in the corticospinal tract after spinal cord injury.  
In paper III, we identified a subset of ependymal cells – EpA cells – that harbors the in vitro 
stem cell capacity of the spinal cord and responds to spinal cord injury by both self-
duplicating and generating migrating progeny that differentiates into scar-forming astrocytes 
and oligodendrocytes. By performing single cell RNA sequencing we found that shortly after 
injury, the highly differentiated EpA cells dedifferentiate to acquire a stem cell-like state.  
The work presented in this thesis supports an important role of ependymal cells in the 
response to spinal cord injury, and explores their plasticity as well as the manipulation of 
their lineage fate choices. Lastly, it describes the activation of a subgroup of ependymal 
neural stem cells with the ability to respond to spinal cord injury. Through these studies, we 
have identified and characterized a population of resident neural stem cells that represents a 
promising therapeutic target to treat spinal cord injury.   
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Traumatic spinal cord injuries are life-changing and biologically complex. Millions of people 
worldwide live with long-term disabilities such as motor deficits, loss of bladder control and 
neuropathic pain after spinal cord injury (SCI) (Ahuja et al., 2017; James et al., 2019). Because 
of the significant suffering and care need of SCI patients, considerable research efforts have 
focused on developing treatments promoting spinal cord repair. Despite these efforts, there is 
still no cure, and treatment options are largely limited to managing symptoms, such as pain 
(Widerström-Noga, 2017).  
The spinal cord is organized into grey matter containing nerve cell bodies, and white matter 
containing myelinated nerve fibers, axons. The axons connect the brain with the body and relay 
sensory and motor signals (Ahuja et al., 2017). Traumatic SCI typically results in cut off nerve 
fibers accompanied by massive cell death. The injury is followed by a considerable immune 
reaction, and an invasion and generation of new cells at the injury site. Understanding the role of 
the arriving and newly formed cells in the lesion is of upmost importance to understand how to 
treat SCI. 
Following the initial injury reaction, a scar is formed at the lesion site. The scar consists of a 
fibrotic core infiltrated with inflammatory immune cells, that is surrounded by layers of newly 
formed astrocytes derived predominantly from neural stem cells (NSCs), as well as reactive 
resident astrocytes, and some neural/glial antigen 2 (NG2)-expressing oligodendrocyte 
progenitor cells (OPCs) (Bradbury & Burnside, 2019; Sabelström, Stenudd, & Frisén, 2013). 
The scar is thought to have both a positive effect on the outcome of the injury by stabilizing the 
tissue and controlling the spread of the inflammatory immune reaction, and a negative effect on 
the outcome by blocking regrowth of nerve fibers through the injury site (Bradbury & Burnside, 
2019). One goal of the work presented in this thesis is to understand the role of the NSC-derived 
cells that populate the scar.  
A multitude of studies have focused on achieving regeneration of lost or damaged spinal cord 
tissue (Assinck, Duncan, Hilton, et al., 2017; Barnabé-Heider & Frisén, 2008; Bradbury & 
Burnside, 2019). Many attempts have involved transplanting stem/progenitor cells into the 
spinal cord lesion site. However, transplantation is typically an invasive process with serious 
disadvantages connected to both practical aspects such as the availability of cells to transplant, 
and to our immune system’s reaction to cells from exogenous sources (discussed further in 
section 4). 
The manipulation of endogenous cells may provide an elegant solution to problems associated 
with cell transplantation. Utilizing cells that are already present in an injured tissue to repair it 
does not require invasive procedures or introduce exogenic material to the injured tissue. 
In order to manipulate endogenous stem cells to, for instance, expand their population size or 
alter their fate choices, it is important to identify candidate neural stem cell populations that can 
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be targeted for intervention and to understand their current functions and the mechanisms that 
control them. 
By focusing on these three areas; the function (Paper I), the plasticity (Paper II), and the identity 
(Paper III) of stem cells in the spinal cord, I hope that the work in this thesis can bring us one 
step closer to help the spinal cord repair itself with resident cells.  
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2 REACTION AND REPAIR FOLLOWING SPINAL CORD 
INJURY 
A traumatic insult to the central nervous system is initially mechanical. It causes structural 
damage to neurons and their axons, and the death of neurons and glial cells. The primary insult 
is followed by a cascade of events that leads to both secondary damage and to the sequestration 
of the injured area from surrounding tissue through the formation of a scar (Ahuja et al., 2017; 
Burda et al., 2016).  
This chapter of the thesis will focus on the reaction to traumatic injury and subsequent scarring 
in the adult mammalian spinal cord. The process is similar to the one following traumatic injury 
in the mammalian brain, but there are some differences. For instance, the inflammatory response 
and astrocyte reactivity following spinal cord injury is more widespread compared to after 
traumatic brain injury, and different cell types harbor the stem cell capacity of the spinal cord 
and the brain (Bradbury & Burnside, 2019; Kriegstein & Alvarez-Buylla, 2009; Sabelström, 
Stenudd, & Frisén, 2013; Schnell, 1999) [stem cell identities are covered in chapter 3].  
2.1 ACUTE AND SUBACUTE REACTION TO SPINAL CORD INJURY 
A cascade of events that precede scar formation start shortly after a traumatic SCI. The acute 
period after the injury is characterized by bleeding and local edema (Bradbury & Burnside, 
2019). Already at this early time point, many cells die as a consequence of secondary changes 
directly following the injury, such as cell permeabilization, presence of pro-apoptotic signals and 
ischemia resulting from a disrupted microvascular blood supply to the lesion area. Severe 
swelling, which can result from strong inflammation or disruption of the blood-spinal cord 
barrier, can lead to additional compression damage to the spinal cord (Ahuja et al., 2017).  
Cell damage, cell death and tissue necrosis lead to the activation of microglia in the lesion site, 
starting within minutes after SCI (Jin & Yamashita, 2016; Kroner & Rosas Almanza, 2019). The 
lesion site is subsequently infiltrated by other immune cells such as activated macrophages, 
lymphocytes and neutrophils. Immune cells clear up myelin debris and cell residues from the 
lesion core, but they also release cytotoxins that can generate secondary damage (Kigerl et al., 
2009; X. Liu et al., 2018; Tran et al., 2018). 
Glial cells like astrocytes (resident and ependymal cell-derived) and  oligodendrocyte progenitor 
cells (OPCs), as well as pericyte-derived fibrotic cells are recruited to the lesion area within days 
after SCI. These cells play important roles in modulating the environment after SCI, and they 
form the glial scar that is described in the next section (Barnabé-Heider et al., 2010; Göritz et al., 
2011; Shea et al., 2017).  
After an axon is severed, axonal dieback of the proximal end of the cut will start within half an 
hour, while the distal end will undergo a similar process, called Wallerian degeneration, at a 
later time point (Kerschensteiner et al., 2005). Axons attempting to regrow are found less than a 
day after injury, but they fail to grow in an organized manner and do not pass the glial scar 
(Kerschensteiner et al., 2005). The failure to regrow is likely a result of a combination of 
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environmental factors and the neurons intrinsic capacity to regrow its axon (Bradbury & 
Burnside, 2019; Kerschensteiner et al., 2005). 
The neurons’ intrinsic ability to regenerate their axons is far greater in the peripheral nervous 
system (PNS) compared to in the CNS (Hilton & Bradke, 2017). A regenerating axon in the 
PNS will form a growth cone, which is a structure that contains microtubules organized in the 
directionality of the cut axon (Ertürk et al., 2007; Hilton & Bradke, 2017). The growth cone is 
instrumental for axonal regeneration, and axons cut in the CNS fail to form one (Bradke et al., 
2012). Instead, the tip of a cut axon in the CNS forms a retraction bulb, in which microtubules 
are disorganized (Ertürk et al., 2007).  
Factors in the local environment that limit regrowth of axons include changes in tissue 
architecture following injury and scarring, as well as the local microenvironment in the lesion 
area [discussed in section 2.3].  
2.2 SCARRING AFTER SPINAL CORD INJURY 
A scar is formed at the site of injury. While it is traditionally called the glial scar, it inhabits both 
glial and non-glial cell types. The scar consists of a core with fibroblast-like cells and 
inflammatory immune cells. The scar core is immediately surrounded by a layer of astrocytes, in 
part generated from ependymal cells, which in turn is surrounded by hypertrophic resident 
astrocytes and some NG2-expressing OPCs in the perimeter of the scar (Barnabé-Heider et al., 
2010; Bradbury & Burnside, 2019; Cregg et al., 2014; Göritz et al., 2011; Li et al., 2018; Meletis 
et al., 2008; Soderblom et al., 2013). Scar formation is a dynamic process. The glial scar matures 
with time, and many of the components that start arriving early after injury reach maximal 
densities weeks later. In most mammalian species, a cyst is formed in the center of the  scar 
(Bradbury & Burnside, 2019).  
 
The fibroblast-like cells that populate the scar core are mainly generated from type A pericytes. 
Type A pericyte-derived cells peak at around two weeks after injury (Göritz et al., 2011). The 
fibrotic scar is important for the maintenance of tissue integrity after SCI, but also plays a role in 
blocking axonal regrowth (Dias et al., 2018; Göritz et al., 2011).  
Figure 1 | Glial & fibrotic compartments of the glial 
scar. Illustration of the distribution of glial scar 
components from different sources. In yellow, type A 
pericyte-derived fibroblast-like cells in the scar core. In 
green, ependymal-derived astrocytes. In red, astrocyte 
scar component derived from resident astrocytes. 
Illustration from Stenudd et al., 2015. Used with 




Local and infiltrating immune cells inhabit the scar, and the infiltration of immune cells peaks at 
four weeks after injury (Bellver-Landete et al., 2019; Kigerl et al., 2009). In addition to 
fibroblast-like cells and inflammatory immune cells, the scar core contains extracellular matrix 
(ECM) deposits, as well as glycoproteins such as chondroitin sulfate proteoglycans (CSPGs) 
(Shea et al., 2017). 
The astrocytic component of the glial scar is made up of newly formed astrocytes surrounding 
the lesion core, and reactive astrocytes in the perimeter of the scar. Astrocytes close to the lesion 
core have elongated morphologies, and they come from recently divided cells. Further away 
from the lesion core, the astrocytic scar component consists of hypertrophied, stellate resident 
astrocytes (Barnabé-Heider et al., 2010; Wanner et al., 2013). Newly formed astrocytes are more 
frequently generated from ependymal cells compared to resident astrocytes (Barnabé-Heider et 
al., 2010). The density of glial fibrillary acidic protein (GFAP)-expressing astrocytes only 
increases around 2- to 4-fold after injury compared to uninjured tissue (Ertürk et al., 2012). 
However, this may not give the full picture of the astrocyte population growth, since astrocytes 
derived from ependymal cells do not uniformly express GFAP (Meletis et al., 2008).  
2.3 DUAL ROLES OF ASTROCYTES AND IMMUNE CELLS IN THE GLIAL SCAR 
Immune cells and astrocytes in the scar appear to have both beneficial and detrimental effects 
after SCI.  
The injury reaction by microglia and macrophages plays an important role in the recovery after 
SCI by cleaning up residues from dead cells and myelin debris from the lesion core, but they can 
also contribute to increased inflammation and neuronal death (Kigerl et al., 2009; X. Liu et al., 
2018; Tran et al., 2018). These opposing effects seem to be carried out by different subgroups of 
microglia and macrophages.  
Microglia and macrophages can be subdivided into M1 and M2 subtypes depending on the roles 
they play in the injury response (Kigerl et al., 2009). M1 macrophages are pro-inflammatory and 
neurotoxic, while M2 macrophages act anti-inflammatory and more effectively clears necrotic 
debris. Unfortunately, the M2 response is smaller and lasts for a shorter time compared to the 
M1 macrophage response (Kigerl et al., 2009). Similar to M1 macrophages, M1 microglia are 
neurotoxic and release pro-inflammatory cytokines, while M2 microglia act anti-inflammatory 
(X. Liu et al., 2018). 
The elongated astrocytes surrounding the lesion core contract the scar and function as a border, 
hindering the spread of inflammatory cells from the lesioned tissue to surrounding healthy spinal 
cord tissue and thereby reducing secondary injury (Cregg et al., 2014; Faulkner et al., 2004; 
Herrmann et al., 2008; Okada et al., 2006; Sabelström, Stenudd, Réu, et al., 2013; Wanner et al., 
2013).  
At the same time, a role of glial scar astrocytes in forming a barrier to axonal regrowth has been 
extensively studied in both brain and spinal cord lesions.  
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Molecules in the ECM of the scar, including proteoglycans, ephrins, semaphorins and myelin-
associated proteins (such as Nogo-A), play a role in blocking axonal regrowth (Griffin & 
Bradke, 2020; Schwab & Strittmatter, 2014). Chondroitin sulfate proteoglycans, or CSPGs, are 
expressed by reactive astrocytes as well as other cell types in the scar, such as fibrotic cells in 
the core of the scar. CSPGs can bind to cell surface receptors on neurons and block neurite 
outgrowth (Davies et al., 1999; Fisher et al., 2011; Friedlander et al., 1994; Göritz et al., 2011; 
McKeon et al., 1999; Shen et al., 2009).  
The view of the glial component of the scar as an obstacle to regeneration may be reductionist. 
A study by Anderson et al. (2016) suggested that astrocytes support axonal regrowth by creating 
a permissive environment/bridge, for instance by producing growth-promoting CSPG5. Tran et 
al. (2018), perhaps in an attempt to consolidate the opposing views on the effects of the 
astrocytic scar on axonal regrowth, argue that the role of astrocytes as either a barrier or a bridge 
for axonal regeneration may be dependent on local environmental cues, such as the degree of 
inflammation in the lesion area.  
The, still ongoing, discussion with evidence for both positive and negative effects of the 
astrocytic scar component on recovery from SCI led us to examine the role of the ependymal 
cell generated glial scar component in Paper I. 
2.4 DE- AND REMYELINATION AFTER SPINAL CORD INJURY 
Oligodendrocytes myelinate axons, which is important for neuronal survival and to increase the 
conduction speed of nerve impulses. Oligodendrocytes are sensitive to the microenvironment 
after SCI, and as a result there is a massive loss of oligodendrocytes for days after injury (Giacci 
et al., 2018; X. Z. Liu et al., 1997; F. Sun et al., 2010). The loss of myelinating oligodendrocytes 
is accompanied by demyelination of axons (Pukos et al., 2019; Rabchevsky et al., 2007).  
OPCs are identified by their expression of NG2 and platelet-derived growth factor alpha 
(PDGFRa), and constitute an important source of new myelinating oligodendrocytes after spinal 
cord injury (Assinck, Duncan, Plemel, et al., 2017; Hall et al., 1996; Pringle et al., 1992). OPCs 
proliferate to self-renew and generate oligodendrocytes both in the intact spinal cord and after 
injury (Assinck, Duncan, Plemel, et al., 2017; Barnabé-Heider et al., 2010; Duncan et al., 2020; 
Horner et al., 2000; Kang et al., 2010; F. Sun et al., 2010; Zhu et al., 2011). After injury, they 
give rise to myelinating oligodendrocytes and some Schwann cells (Assinck, Duncan, Plemel, et 
al., 2017; Barnabé-Heider et al., 2010; Kang et al., 2010). The production of new 
oligodendrocytes from OPCs continues for months after injury (Hesp et al., 2015). A fate 
mapping study by Assinck et al. (2017) reported that approximately 30% of new myelin sheets 
found in a lesion three months after SCI were generated by oligodendrocytes produced by OPCs 
after the injury. A small portion of remyelinating oligodendrocytes are also produced from 
ependymal cells (Barnabé-Heider et al., 2010; Meletis et al., 2008). 
Remyelination is an important goal for therapies aiming to improve functional outcome after 
spinal cord injury. As a result, improving the availability of remyelinating cells is a goal of many 
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therapeutic efforts. In paper II, we examine the feasibility and effects of increasing the 
oligodendrocyte generation by ependymal cells.
 
14 
3 NEURAL STEM CELLS IN THE ADULT CENTRAL 
NERVOUS SYSTEM 
When discussing the identities of stem cells, it seems appropriate to start by considering what 
a stem cell is. Traditional definitions of stem cells typically focus on two areas: multipotency, 
which is a cells ability to generate cells of different types, and self-renewal, which indicates a 
cells ability to self-duplicate to generate new multipotent stem cells (Gage, 2000). 
For years, the prevailing view was that no new nerve cells are born in the adult central 
nervous system. However, evidence of adult neurogenesis has slowly accumulated since the 
60’s, when Joseph Altman and Gopal Das found new-born neurons in the olfactory bulb and 
dentate gyrus in the hippocampus of adult rats (Altman, 1962; Altman & Das, 1965). 
Initially, the work by Altman and Das did not attract large interest and the research efforts in 
this field were limited. Almost two decades later, new-born neurons that integrated into 
functional circuits were found in adult canary birds (S. A. Goldman & Nottebohm, 1983).  
The interest in the regenerative abilities of the mammalian CNS grew in the early 90’s, when 
a few research groups showed that it’s possible to isolate NSCs from the brain of adult 
rodents and expand them in vitro (Reynolds & Weiss, 1992; Richards et al., 1992). In the late 
90’s, elegant work by Eriksson et al. (1998) showed that new nerve cells are born during 
adulthood in the human hippocampus. This seminal work has been followed by the 
characterization of adult neurogenesis in the human brain, where new neurons are born 
throughout our lives (Ernst et al., 2014; Spalding et al., 2013). The situation is different in the 
spinal cord, and there is to date no compelling evidence supporting neurogenesis in the adult 
spinal cord.  
NSCs are present in both the brain and the spinal cord, and the potential of using their 
capacity to repair injuries in the central nervous system have fascinated researchers during the 
last decades (Doetsch et al., 1999; Johansson et al., 1999; Meletis et al., 2008; Suh et al., 
2007). This chapter will cover the identity and functions of NSCs in the CNS. 
3.1 THE BRAIN  
The subventricular zone (SVZ) of the lateral ventricle walls, and the subgranular zone (SGZ) 
of the dentate gyrus in the hippocampus are the two main NSC niches in the adult 
mammalian brain (Bonaguidi et al., 2011; Doetsch et al., 1999; C. Lois & Alvarez-Buylla, 
1993; Suh et al., 2007). The NSCs of the adult brain are astrocyte-like cells (Doetsch et al., 
1999; Kempermann et al., 2015; Seri et al., 2001).  
3.1.1 The subventricular zone 
NSCs, sometimes referred to as type B cells, reside in the SVZ of the mammalian brain. Type 
B cells can generate neurons, astrocytes and oligodendrocytes both in vitro and in vivo 
(Calzolari et al., 2015; C. Lois & Alvarez-Buylla, 1993; Menn et al., 2006; Sohn et al., 2015).  
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The most extensively studied process starting from type B cells is the birth of new neurons. 
Type B cells cycle between a quiescent and an active (proliferating) state (Basak et al., 2018). 
Active type B cells divide to self-renew and/or produce rapidly dividing transit-amplifying 
cells that, in turn, give rise to neuroblasts that migrate to form neurons in the olfactory bulb in 
mice (Calzolari et al., 2015; Carlos Lois et al., 1996).  
Stem cells in the SVZ are functionally heterogeneous. Distinct pools of SVZ stem cells can 
generate either neurons and astrocytes or oligodendrocytes, while the same cell does not 
typically generate all three (Ortega et al., 2013). However, lineage plasticity can be unlocked 
by demyelinating lesions, leading to the generation of oligodendrocytes from NSCs that 
typically give rise to neurons (Jablonska et al., 2010). Different olfactory bulb interneuron 
types are generated by different committed NSCs that populate distinct regions of the SVZ 
(Merkle et al., 2007; Young et al., 2007). 
In humans, no new neurons are formed in the olfactory bulb (Bergmann et al., 2012). Instead, 
neural stem cells in the subventricular zone are a plausible source of adult-born neurons in the 
striatum (Ernst et al., 2014). 
In response to ischemic injury in mice, quiescent type B cells are activated. They transition 
from quiescence to an active state via a primed quiescent state (Llorens-Bobadilla et al., 
2015). During the transition, protein synthesis and cell-cycle mRNA expression increase 
(Llorens-Bobadilla et al., 2015). After cortical injury, type B cells give rise to astroglial cells 
in the glial scar (Benner et al., 2013). NSCs in the SVZ generate new neurons in the striatum 
after ischemic injury (Arvidsson et al., 2002; Yamashita et al., 2006). Although, this response 
is limited and the number of striatal neurons that are born corresponds to around 1 in 500 lost 
neurons (Arvidsson et al., 2002). In other words, despite the neurogenic capacities of the 
region, the injury response in the SVZ is leads to a refocus of NSCs towards gliogenesis. 
3.1.2 The subgranular zone of the hippocampus 
In the SGZ of the dentate gyrus in the hippocampus, radial glia-like cells are the source of 
adult neurogenesis as well as astrogenesis. Radial glia-like cells generate intermediate 
progenitor cells that, in turn, give rise to either astrocytes or migratory neuroblasts that 
mature into hippocampal granule cells (Bonaguidi et al., 2011; Kempermann et al., 2015). 
Radial glia-like cells in the SGZ do not generate oligodendrocyte lineage cells under 
physiological conditions, however they can be activated to produce oligodendrocytes by the 
inactivation of the neurofibromin 1 gene (G. J. Sun et al., 2015). In the human hippocampus, 
new neurons are born throughout our lives (Spalding et al., 2013). 
The process of ongoing neurogenesis in the adult brain has generated substantial research 
interest, in particular in the hippocampus where new neurons appear to play a role in our 
ability to learn (Schmidt-Hieber et al., 2004). The radial glia-like cells’ reaction to injury is 
not as extensively studied. However, in response to neural hyperexcitation, which is a 
hallmark of epilepsy, radial glia-like stem cells in the SGZ are activated and start dividing. 
Depending on the degree of hyperexcitation, they divide asymmetrically to produce one 
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intermediary progenitor cell and one astrocyte, or symmetrically to produce two reactive 
astrocytes. Both of these injury reactions deplete the SGZ radial glia-like population and 
exhaust adult hippocampal neurogenesis (Sierra et al., 2015).  
3.2 THE SPINAL CORD  
While functional roles of neural stem- and progenitor cells can be studied in the brain under 
physiological conditions, it is an uneventful endeavor in the spinal cord where we do not 
observe any NSC activity under physiological conditions (Barnabé-Heider et al., 2010; Sohn 
et al., 2015). Instead, functional studies on NSCs in the spinal cord typically focus on in vitro 
stem cell activity, or on the context of injury or disease (Cusimano et al., 2018; Grégoire et 
al., 2015; Johansson et al., 1999; Lacroix et al., 2014; Li et al., 2016; Meletis et al., 2008; 
North et al., 2015; Sabelström, Stenudd, Réu, et al., 2013).  
Different glial cell types, including astrocytes, NG2-expressing oligodendrocyte progenitor 
cells (OPCs) and ependymal cells, have been suggested to harbor the NSC potential of the 
adult spinal cord (Horner et al., 2000; Johansson et al., 1999; Ohori et al., 2006). Fate 
mapping studies have failed to show differentiation to multiple glial lineages from 
astrocytes (Sabelström, Stenudd, & Frisén, 2013). Most studies in both young and adult 
mice support that NG2-expressing OPCs only generate myelinating cells and new OPCs 
after injury (Assinck, Duncan, Plemel, et al., 2017; Barnabé-Heider et al., 2010; Kang et al., 
2010; Zhu et al., 2011). Nonetheless, there is some evidence suggesting that NG2-
expressing OPCs may be capable of astrocyte differentiation after SCI (Hackett et al., 2016; 
Huang et al., 2018). In contrast, there is a multitude of studies showing self-renewal and 
multilineage differentiation from ependymal cells in the adult spinal cord. 
3.2.1 Spinal cord ependymal cells act as neural stem cells after spinal cord 
injury 
Under physiological conditions, ependymal cells do not show stem cell activity. Instead, they 
remain around the central canal and proliferate slowly to produce new ependymal cells 
(Barnabé-Heider et al., 2010; Horner et al., 2000; Meletis et al., 2008; Sohn et al., 2015). 
However, they start proliferating vigorously within 24 hours after SCI (Barnabé-Heider et al., 
2010; Beattie et al., 1997; Johansson et al., 1999; Lacroix et al., 2014; Meletis et al., 2008). 
Around three days after injury, ependymal cell progeny starts leaving the central canal. 
Migrated ependymal progeny differentiate into both scar-forming astrocytes and 
oligodendrocyte lineage cells, including myelinating oligodendrocytes. While generating 
migrating progeny, the ependymal cells are able to self-renew sufficiently to maintain their 
own population (Barnabé-Heider et al., 2010; Johansson et al., 1999; Li et al., 2018; Meletis 
et al., 2008; A. Mothe & Tator, 2005; North et al., 2015).  
Neurosphere culture experiments point in the same direction. Unlike astrocytes or OPCs, 
cells from the ependymal cell population divide to efficiently produce neurospheres in vitro. 
Ependymal cell-derived neurosphere cultures generate increasing numbers of neurospheres 
over multiple passages (Barnabé-Heider et al., 2010; Meletis et al., 2008; Pfenninger et al., 
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2011). Neurospheres generated from ependymal cells are multipotent, and can be 
differentiated into all three neural lineages (astrocytes, oligodendrocytes and neurons) in vitro 
(Barnabé-Heider et al., 2010; Johansson et al., 1999; Meletis et al., 2008). Cells from the 
ependyma of the injured spinal cord expand faster in vitro. They generate more neurospheres, 
which grow larger, compared to cells from the uninjured spinal cord (Barnabé-Heider et al., 
2010; Li et al., 2018; Moreno-Manzano et al., 2009).  
In conclusion, multiple lines of evidence support that cells within the ependymal cell 
population are activated by injury or in vitro to act as NSCs in the spinal cord (Barnabé-
Heider et al., 2010; Johansson et al., 1999; Li et al., 2018; Meletis et al., 2008; A. Mothe & 
Tator, 2005).  
This means that different cell types carry the NSC capacity of the brain and spinal cord, since 
ependymal cells do not display stem cell qualities in the brain. Ependymal cells around the 
lateral ventricles are activated and generate migrating progeny in response to stroke in the 
adult brain, but they fail to self-renew sufficiently and are depleted in the process (Carlén et 
al., 2009). Instead, the stem cells of the SVZ in the brain are astrocyte-like type B cells.  
Most of the studies cited above contain data on neural stem cells in mice and rats. Less is 
known about the stem cell potential of ependymal cells in humans. Of note, no cell division 
has been detected in the human ependyma using antibody staining against the Ki67 antigen, 
which is expressed by proliferating cells. This implies that ependymal cells in the spinal cord 
of adult humans either divide very rarely, or not at all (Becker et al., 2018). Meanwhile, 
efficiently self-renewing and multipotent cells from the human spinal cord can be grown and 
passaged in neurosphere assays (A. J. Mothe et al., 2011).  
While stem cells in the spinal cord respond to SCI and can differentiate into neurons in vitro, 
they are not known to give rise to neurons in vivo (Barnabé-Heider et al., 2010). Intriguingly, 
a study by Shihabuddin et al. (2000) revealed that spinal cord-derived NSCs that have been 
expanded in vitro can generate neurons in vivo in neurogenic regions, even if they do not give 
rise to new neurons in the spinal cord. Upon transplantation of NSCs from the rat spinal cord 
into the hippocampus, some NSCs derived from the spinal cord gave rise to cells closely 
resembling hippocampal granular neurons. This demonstrates an inherent plasticity and a 
sensitivity to the microenvironment surrounding NSCs that may be interesting to explore 
further in the context of manipulating the ependymal cells’ response to SCI.  
3.2.2 Characteristics of and heterogeneity within the ependymal stem cell 
niche in the adult spinal cord 
Spinal cord ependymal cells line the central canal. Ependymal cells have motile cilia 
propelling cerebrospinal fluid, and they form a barrier between the cerebrospinal fluid and the 




Ependymal cells in the adult spinal cord are morphologically heterogeneous, with three 
distinct morphologies that have been identified using electron microscopy. The most common 
morphology is a multi-ciliated cuboidal cell with no dorsal process. Another common 
morphology is tanycytic, which describes an ependymal cell with a single cilium, and a single 
dorsal process. The least common morphological subtype is the radial ependymal cell, which 
is typically located in the dorsal or ventral pole of the central canal and have a long dorsal 
process (Bruni & Reddy, 1987; Meletis et al., 2008; Seitz et al., 1981).  
Ependymal cells uniformly and, in the spinal cord, exclusively express motile cilia related 
molecular markers such as forkhead box protein J1 (FoxJ1) (Ghazale et al., 2019; Zeisel et 
al., 2018). Other molecular markers, such as the immature neural cell-associated proteins 
brain lipid-binding protein (BLBP) and Nestin, as well as the cannabinoid receptor 1 protein 
(CB1), are unevenly distributed within the ependymal layer (Garcia-Ovejero et al., 2013; 
Hamilton et al., 2009; Sabourin et al., 2009).  
While most characterization of ependymal cells and their stem cell capacities has been done 
in rodents, a recent study compared the ependymal layer of mouse and human (Ghazale et al., 
2019). A set of 120 transcription factors expressed in ependymal cells in both mouse and 
human were picked out. Some of these transcription factors are expressed only in a small part 
of the ependymal layer, such as the ventrally located aristaless related homeobox (ARX) and 
forkhead box A2 (FOXA2), and the dorsally located msh homeobox 1 (MSX1). This dorsal-
ventral patterning was conserved between the species, as well as the expression of some 
frequently used molecular markers for ependymal cells and their progeny (i.e. Foxj1, Pax6, 
and Sox9) (Ghazale et al., 2019). In summary, even though differences have been reported, 
there seems to be significant similarities between rodent and human spinal cord ependymal 
cells.   
While the ependymal cell population contains cells that unlock NSC activity in vitro and after 
SCI, the ependymal layer in mice also encompasses cells that lack stem cell qualities. Two 
studies have used the GFAP promoter to label a small group of ependymal cells located 
predominantly in the dorsal ependymal layer, and found that this subpopulation is enriched 
for primary neurosphere forming capacity. However, these cells do not self-renew efficiently 
in vitro, and they are lost when the neurosphere cultures are passaged (Fiorelli et al., 2013; 
Sabourin et al., 2009). 
The heterogeneity within the ependymal cell population, together with the observation that 
not all ependymal cells act as stem cells in vitro prompted us to investigate the identity of the 
ependymal cell subpopulation that displays stem cell qualities. The identification and 
characterization of ependymal neural stem cells is the topic of Paper III.   
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4 CELL-BASED METHODS TO IMPROVE RECOVERY 
FROM SPINAL CORD INJURY 
Studies aimed at repairing the injured spinal cord have focused largely on cell transplantation,  
and while many cell transplantation studies have shown promising results, transplantation has 
limitations depending on the source of cells, and is often an invasive procedure (Assinck, 
Duncan, Hilton, et al., 2017; Barnabé-Heider & Frisén, 2008). Manipulating cell types 
already present in the injured spinal cord may therefore be an attractive alternative to cell 
transplantation, although endogenous stem/progenitor cell manipulation in the spinal cord is 
not as extensively studied, and there is a lot left to learn. This chapter will describe research 
on different cell-based therapies aimed at improving functional recovery after SCI, and 
highlight the outstanding gaps in knowledge concerning their efficiency and feasibility. 
4.1 CELL TRANSPLANTATION 
Researchers have transplanted cells from a wide range of sources to the injured spinal cord. 
Many studies have shown promising results, including limiting cell death through the release 
of trophic factors, replacing lost cells, and improving functional recovery (Assinck, Duncan, 
Hilton, et al., 2017). Some cell types used for such transplantation include mesenchymal stem 
cells, olfactory ensheathing cells, oligodendrocyte progenitor cells and neural stem and 
progenitor cells.  
Mesenchymal stem cells (MSCs) are tissue stem cells found in, for instance, the adult bone 
marrow. Transplantation of mesenchymal stem cells to the spinal cord lesion can limit lesion 
size and exert a neuroprotective and immunomodulatory effect (Assinck, Duncan, Hilton, et 
al., 2017; Gu et al., 2010), which may result from secreted trophic factors following MSC 
transplantation (Hawryluk et al., 2012). Given the positive effects attributed to modulating 
the local lesion microenvironment, as well as the relative ease of harvesting (also autologous) 
MSCs, this is a widely studied approach to treat SCI. Furthermore, a small number of clinical 
studies have employed autologous bone marrow mesenchymal stem cell transplantation to 
treat chronic spinal cord injuries. While these studies have been small or non-randomized, 
improvement in American Spinal Cord Injury Association (ASIA) Impairment Scale (AIS) 
scores were observed for some participants (Dai et al., 2013; El-Kheir et al., 2014).  
Olfactory ensheathing cells (OECs), which ensheath unmyelinated axons in the olfactory 
system, have gathered interest as a candidate cell population for cell transplantation to 
promote functional recovery after SCI. Transplantation of OECs cells can protect neural 
tissue by releasing neurotrophic factors, and support axonal regeneration and sprouting 
(Barbour et al., 2013; Takeoka et al., 2011). A few small and non-randomized clinical trials 
have adopted this approach, with one reporting improved functionality scores after 
autologous OEC transplantation in a phase I human clinical trial (Tabakow et al., 2013). 
However, another small clinical trial using OECs from the olfactory mucosa reported 
considerable variability between the treated patients, and most did not experience significant 
improvement in AIS scores (Wang et al., 2016). In summary, despite some encouraging 
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findings, the clinical evidence for OEC transplantation eliciting a functional improvement in 
humans is still weak (Tabakow et al., 2013; Yao et al., 2018).  
OPCs, which produce myelinating cells in the CNS, can be transplanted to the injured spinal 
cord. OPCs for transplantation can be derived, for instance, from iPS cells or human 
embryonic stem cells (Kawabata et al., 2016; Keirstead et al., 2005), and there is a growing 
body of evidence supporting that OPCs transplanted to the injured rodent spinal cord can 
support remyelination, reduce cavity size in the glial scar, and improve functional recovery 
(Fu et al., 2018; Kawabata et al., 2016; Keirstead et al., 2005).  
Neural stem/progenitor cells transplanted to the spinal cord can promote functional recovery 
via various means, such as through immunomodulation, by promoting axonal 
sprouting/regrowth, or by inducing axon remyelination (Assinck, Duncan, Plemel, et al., 
2017). NSCs derived from various sources, such as from differentiated embryonic cells and 
from the adult spinal cord, can produce astrocytes, oligodendrocytes and (typically few) 
neurons when transplanted into the injured spinal cord of adult rodents (Hofstetter et al., 
2005; Yasuda et al., 2011).  
Transplantation of in vitro expanded NSCs derived from adult rat spinal cord into injured rat 
spinal cord can facilitate a functional improvement. However, most transplanted NSCs 
differentiate into astrocytes (Hofstetter et al., 2005). Specifically, while neural stem cells 
derived from adult rat spinal cord have the capacity to generate neurons as well as astrocytes 
and oligodendrocytes in vitro or when transplanted into a neurogenic region (Shihabuddin et 
al., 2000), the environment in the spinal cord stimulates glial differentiation. Furthermore, 
rats that received transplantations suffered from allodynia, a condition characterized by 
sensations of pain elicited by stimulus that typically does not cause pain. These symptoms 
may have been a result of the large share of astrocyte differentiation, as stimulating 
oligodendrocyte differentiation at the expense of astrocyte differentiation by overexpressing 
Ngn2 in NSC transplants helped remedy the symptoms (Hofstetter et al., 2005). 
Neural stem cells transplanted to the injured spinal cord can restore connectivity across the 
lesion site. Grafting neural stem cells within a growth factor-enriched fibrin matrix can 
generate an extensive neuronal differentiation (>25% of transplanted cells), with newly-
generated neurons extending long axons into host tissue. These axons are often myelinated by 
host-derived oligodendrocytes, and the transplantation leads to improvements in locomotion 
after only a few weeks (Lu et al., 2012). In a follow-up study in rhesus monkeys, neural 
progenitor cells derived from human embryonic stem cells were transplanted within a growth 
factor-enriched fibrin matrix to spinal cord lesions. Immunosuppressive treatment was used 
to manage the immune reaction against the grafted cells. Substantial axonal regrowth across 
the lesion site was observed after transplantation, which were coupled with functional 
recovery after 10 weeks and onwards. Transplanting cells with a matrix modulating their 
local environment can offer enhanced control over the fate of transplanted stem cells, and the 
results in rhesus monkey suggest that the method can be suitable for clinical translation. 
(Rosenzweig et al., 2018). A small clinical trial with no control group has shown that NSC 
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transplantation into human spinal cord lesions can be conducted safely, and while some 
functional improvement was recorded in two out of four patients, the evidence for functional 
recovery as a result of NSC transplantation in human is still limited (Curtis et al., 2018). 
Cell transplantation therapies may have the potential to rescue structure and function 
following spinal cord injury. However, the limitations posed by immune reactivity or 
feasibility of collecting cells for autologous transplantation therapies, as well as concerns 
regarding safety partially remain. For this reason, it is relevant to explore manipulation of 
endogenous cells as an alternative to transplantation.  
4.2 MANIPULATION OF ENDOGENOUS NEURAL STEM AND PROGENITOR 
CELLS 
Many outstanding questions remain on the topic of manipulating endogenous cells in vivo to 
treat spinal cord injuries. A few investigations have, however, contributed towards some 
understanding of processes that may be interesting to explore further for modulating the 
cellular response to spinal cord injury.  
Astrocytes are the most abundant glial cells in the central nervous system and given their 
prevalence, they have been extensively studied to understand what function they offer in the 
glial scar, by which signals they are controlled, and whether these regulatory processes can be 
exploited to improve functional recovery after injury. The astrocytic component of the glial 
scar has both beneficial and detrimental effects on recovery, and targeted manipulations could 
aim to adapt astrocytic scars to only have beneficial effects on recovery. For example, a 
therapy may ensure the formation of a barrier that restricts inflammatory cells to the lesion 
core without blocking axonal regrowth.    
The Janus kinase-signal transducers and activators of transcription (JAK-STAT) family of 
signaling has been implicated as a potential regulator of astrogenesis during development 
(Bonni et al., 1997). Conditional deletion of a member of the JAK-STAT family, Stat3, in 
astrocytes highlights that Stat3 is needed for astrocyte hypertrophy and Gfap upregulation, 
migration, and importantly for the recruitment and organization of the elongated astrocytes 
that form a scar border between the lesion and the surrounding tissue. Without Stat3 
expression in astrocytes, lesions grow larger with an increased spread of inflammation, which 
ultimately inhibits motor function recovery (Herrmann et al., 2008; Okada et al., 2006; 
Wanner et al., 2013). On the contrary, conditional ablation of the suppressor of cytokine 
signaling 3 (Socs3) gene leads to an increased astrocyte migration and an improved barrier 
function that restricts inflammatory cells to the lesion epicenter. Socs3 ablation also leads to 
increased scar contraction and improved motor function (Okada et al., 2006).  
However, these studies base the assumption that conditional deletion of Stat3 or Socs3 is 
restricted to just astrocytes on the presence of Gfap or Nestin expression, two genes which 
are not exclusively expressed in these cells. As a result, the source of the scar-forming 
astrocytes that are affected by the modulation of Stat3 and Socs3 cannot be determined 
(Herrmann et al., 2008; Okada et al., 2006; Wanner et al., 2013). They may be stemming 
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from resident astrocytes or from ependymal neural stem cells (Barnabé-Heider et al., 2010). 
In fact, the localization in the scar and some of the effects of blocking Stat3 are reminiscent 
ependymal-derived astrocytes’ behavior after injury. Ependymal cell-derived astrocytes 
localize to a region close to the lesion core (Barnabé-Heider et al., 2010; Sabelström, 
Stenudd, & Frisén, 2013), and blocking the ependymal cell contribution to the glial scar leads 
to worsened secondary damage (Paper I; Sabelström, Stenudd, Réu, et al., 2013).  
The ability of ependymal cells to activate stem cell features after injury and generate cells of 
other lineages pinpoints them as an interesting target for endogenous modulation (Barnabé-
Heider et al., 2010; Llorens-Bobadilla et al., 2020; Sabelström, Stenudd, & Frisén, 2013). In 
spite of this potential, our current knowledge of signals that activate ependymal cells and 
regulate their fate choices is limited.  
As one of the few molecules to have been examined in this regard, ß1-integrin expression is 
integral in controlling ependymal cells’ ability to generate progeny. Without it, ependymal 
cells are unable to self-renew to maintain their own population while giving rise to migrating 
progeny (North et al., 2015). Furthermore, without ß1-integrin expression, migrated 
ependymal progeny expresses Vimentin and Nestin to a lesser extent, while a larger fraction 
expresses Gfap. These changes were associated with a worsened locomotor recovery after 
spinal cord injury. The ablation of ß1-integrin also results in decreased expression of Bone 
Morphogenic Protein Receptor 1a (BMPR1a), whose signaling typically exerts a beneficial 
effect on the glial scar by limiting inflammatory infiltration (Sahni et al., 2010). In the SGZ 
of the hippocampus, BMPR1a signaling regulates proliferation (Mira et al., 2010). These 
results suggest that ß1-integrin plays a role in ependymal cell self-renewal and fate 
determination in the glial scar, potentially by modulating BMP signaling. 
In paper II, we redirected the fate of ependymal neural stem cell progeny by forced 
expression of the Olig2 transcription factor that is essential for the development of the 
oligodendrocyte cell lineage (Zhou & Anderson, 2002). While this approach is unlikely to be 
employed in clinical practice, the study serves as a proof of concept by pinpointing a function 
of ependymal cells that is attractive to promote, and examining what we may be able to 
achieve with such a modulation.  
Progress has been made towards an understanding of post-injury processes that pose 
interesting targets for manipulation. In addition, some studies have shown exciting effects 
from modulating cell populations in the glial scar. However, for an efficient and robust 
modulation of endogenous cells, a thorough understanding of the identity, roles and 




5 PRESENT INVESTIGATION 
5.1 AIMS 
Paper I – To examine the function of the ependymal neural stem cell response to spinal cord 
injury 
Paper II – To uncover mechanisms underlying lineage potential of ependymal neural stem 
cell progeny after spinal cord injury, and to redirect their fate after spinal cord injury 
Paper III - To narrow down the identity of the endogenous neural stem cells in the spinal cord 




5.2 PAPER I  
After spinal cord injury, more than half of the newly generated astrocytes in the glial scar are 
ependymal cell-derived (Barnabé-Heider et al., 2010; Meletis et al., 2008). The effects of the 
different components of the glial scar remain debated, and both beneficial and detrimental 
effects on recovery have been attributed to various parts of the scar (Anderson et al., 2016; 
Bradbury & Burnside, 2019; Dias et al., 2018; Faulkner et al., 2004; Horn et al., 2008; Okada 
et al., 2006; Silver, 2016; Wanner et al., 2013). In Paper I, we examined the function of the 
scar component generated by ependymal neural stem cells after SCI.  
We used a transgenic mouse that let us block the generation of ependymal cell progeny so 
that they could not be recruited to form the ependymal cell-derived glial scar compartment 
after injury. We employed a Cre-loxP mouse, where tamoxifen induced recombination 
specifically in cells expressing FoxJ1 (Meletis et al., 2008), which led to expression of yellow 
fluorescent protein (YFP) under the Rosa26 locus, as well as to a complete deletion of the 
Ras genes, which are necessary for a cells ability to proliferate and migrate (Drosten et al., 
2010).  
Figure 2 | Inducible labeling and conditional complete deletion of Ras genes in ependymal cells. 
(A) Schematic description of the strategy used to facilitate induction of YFP labeling and conditional 
knock-out of the k-Ras gene in ependymal cells. (B) Experimental setup. Genetic alterations were 
induced with tamoxifen. A week later, incision injuries were made. In addition to histological analyses 
at one week and 14 weeks, some injuries were followed for up to nine weeks using repeated MRI 
imaging.  
Illustrations from Sabelström et al., 2013. Reprinted with permission from the American Association 
for the Advancement of Science (Science).  
Proliferation in recombined ependymal cells was severely reduced in acute spinal cord 
injuries of mice with complete Ras gene knockout. In these mice, almost no progeny was 
found to have left the central canal one week after injury. Meanwhile, ependymal cells in 
control mice proliferated vigorously after injury and generated migrating progeny.  
In a majority of chronic injuries, we saw a phenotype ranging from mild tissue defects (less 
compacted scars) to the formation of large cysts at the lesion site. While cyst formation 
occurs after SCI in most mammalians (Ahuja et al., 2017; Bradbury & Burnside, 2019), we 
do not typically observe them in the injury model we used, and no cysts were formed in the 




Furthermore, lesions in mice with a 
blocked ependymal neural stem cell 
injury response grew deeper 
compared to lesions in controls, with 
more axons in the dorsal 
corticospinal tract severed in a 
process secondary to the initial cut.  
Also, more neurons died in mice 
without the ependymal neural stem 
cell injury response (Figure 3). We 
found that ependymal cells and their 
progeny express some neurotrophic 
factors, such as ciliary neurotrophic 
factor (CNTF), hepatocyte growth 
factor (HGF), insulin-like growth 
factor 1 (IGF1), and transforming 
growth factor beta (TGFß), which 
may explain how ependymal cells 
support neuronal survival after SCI 
(Hawryluk et al., 2012; Kitamura et 
al., 2007; Tripathi & McTigue, 
2008).  
It is important to understand the 
functions and current behavior of 
biological processes when one wishes 
to alter them. And, indeed, altering the 
behavior of ependymal neural stem 
seems interesting given how our results 
suggest an important role of their 
progeny formation in the injury 
response.   
Our results suggest that a complete or 
near-complete blockade of the 
ependymal NSC response to SCI is 
associated with increased secondary 
damage, which is likely to be 
associated with a worse functional 
outcome. However, the question of 
whether a less severe blockade of 
ependymal neural stem cells’ activity, 
or a temporally restricted one, could be 
A. Intact spinal cord
B. Chronic injury
C. Chronic injury: without neural stem cell injury response
Injury with ependymal-derived astrocytes
Injury
NeuronCorticospinal tract
Figure 3 | Long-term consequences of lacking 
ependymal neural stem cell proliferation after 
spinal cord injury. (A) An intact spinal cord, showing 
the ependymal cells residing around the central canal 
in green. (B) A spinal cord with an incision injury, and 
an unaltered ependymal cell reaction to the injury. The 
injury model leaves spared nerve fibers in the 
corticospinal tract. Ependymal cell progeny produces a 
scar component that prevents secondary damage of 
axonal tracts as well as neuronal death. (C) A spinal 
cord with the same incision injury model, and an 
ablated ependymal cell response to spinal cord injury. 
The injury is deeper, additional axonal tracts are 
severed, and less spared neurons are present at the 
lesion site. 
Illustration from Stenudd et al., 2015. Used with 
permission from the American Medical Association. 
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beneficial remains. This has been studied in type A pericytes that give rise to fibroblast-like 
cells in the scar core. When Dias et al. (2018) moderately reduced the fibrotic scar formation 
by type A pericytes after SCI, they noted increased axonal sprouting through and beyond the 
scar, resulting in improved sensorimotor recovery.  
Because of the large tissue defects and cysts found in many of the chronic samples from mice 
without an ependymal cell injury response, the effect on axonal regrowth by ependymal cell-
derived scar components could not be examined. If the ependymal cell-generated astrocytic 
scar component would have a negative effect on axonal regrowth or sprouting, it could be 
motivated to reduce the production of the astrocytic scar component from ependymal cells.  
Some findings of this paper, such as the role of ependymal cells in limiting secondary 
damage, and their neurotrophic factor expression, have been validated by other researchers, 
as well as expanded on by examining locomotor function after SCI without an ependymal cell 
response. The researchers found worsened locomotor recovery after removing the ependymal 
cells responding to SCI (Cusimano et al., 2018). With these results in mind, it could be 
interesting to examine whether an overall increase of ependymal cell progeny formation 
would be beneficial for recovery.  
In contrast to the findings of our lab and others, a recent publication found only a minor 
contribution to scar-forming cells from ependymal progeny (Ren et al., 2017). The authors 
suggested that the reason for the large discrepancy between our findings and theirs, may be 
our use of the dorsal funiculus incision injury model, which in theory may directly harm 
ependymal cells. In this article, we use a superficial incision injury, where we see spared 
nerve fibers in the corticospinal tract of control mice, implying that we could not have 
severed the ependymal layer directly. We also see a significant reaction by ependymal cells 
after contusion and crush injuries in paper II and III. Furthermore, the authors raised concern 
about the fidelity of the human Foxj1 promoter that we use (Meletis et al., 2008). We have 
confirmed that Foxj1-CreERT2 recombined ependymal cells (and Troy-CreERT2 recombined 
ependymal cells that were studied in Paper III) express FoxJ1 at the mRNA and protein 
levels. Moreover, in paper III, we traced the progeny of EpA ependymal cells using a non-
Foxj1 dependent CreERT2 mouse line (Troy-CreERT2). A recent study suggests that Foxj1 is 
important for the ependymal cell reaction to spinal cord injury (Li et al., 2018). The loss of 
Foxj1 expression on one allele in the FoxJ1-CreER knock-in line used by Ren et al. 
(Muthusamy et al., 2014) may explain their finding of a minimal injury reaction.  
In summary, Paper I ties functions including limiting secondary growth of spinal cord lesions 
and limiting neuronal death to ependymal cells and ependymal cell-derived astrocytes in the 
glial scar. The study sheds some light on the roles of a subtype of cells in the astrocyte 
component in the glial scar, and shows us that ependymal cells can constitute an interesting 




5.3 PAPER II  
Ependymal cells in the spinal cord respond to injury by dividing rapidly and generating 
astrocytes in the glial scar as well oligodendrocytes, although the contribution to the 
oligodendrocyte lineage is minimal (Barnabé-Heider et al., 2010). Increasing the supply of 
oligodendrocytes via cell transplantation improves remyelination and functional recovery 
after spinal cord injury (Kawabata et al., 2016; Salewski et al., 2015; Yasuda et al., 2011). 
For that reason, we set out to explore if promoting an oligodendrocyte fate choice from 
endogenous cells could improve outcome after spinal cord injury.   
In paper II, we used single cell ATAC-seq data (Satpathy et al., 2019) integrated with single 
cell RNA-seq data (from Zeisel et al., 2018) to assess the lineage potential of ependymal cells 
and other scar-forming populations in the spinal cord by integrating their gene expression and 
chromatin accessibility patterns (Figure 4).
 
To this end, we sorted cells extracted from the uninjured and injured spinal cord of mice with 
an induced expression of tdTomato under the Foxj1-CreERT2 promoter (Foxj1-tdT in Figure 
5). We collected a population of cells enriched for, but not always expressing, tdTomato – 
meaning we collected both recombined ependymal cells and other cell types present in the 
intact and injured spinal cord. In the integrated ATAC-seq and RNA-seq data sets, we found 
clusters containing astrocytes, oligodendrocyte lineage cells, vascular endothelial cells, 
pericytes, and ependymal cells. Looking at the ATAC-seq data of the different clusters, we 
found that Olig2 and Sox10 binding sites were accessible not only in oligodendrocyte lineage 
cells, as expected, but also in ependymal cells. While both Olig2 and Sox10 are expressed by 
oligodendrocyte lineage cells, neither is expressed by ependymal cells. 
Figure 4 | Illustration of single cell chromatin 
accessibility experiment. Fluorescence activated 
cell sorting (FACS) was used to obtain a sample 
of spinal cord cells enriched for recombined 
tdTomato expressing ependymal cells. The 
collected sample was used for single cell ATAC-
seq, which was combined with RNA-seq data to 
study chromatin accessibility in cells from 
different populations in the mouse spinal cord. 
Illustration from Llorens-Bobadilla et al. (2020). 
Used with permission from American Association 
for the Advancement of Science (Science).  
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Finding chromatin accessibility patterns 
showing permissiveness for 
oligodendrogenesis programs prompted 
us to ask whether we could activate 
oligodendrogenesis by activating the 
expression of the Olig2 gene. To this 
end, we generated a transgenic mouse 
line allowing for simultaneous induction 
of Olig2 expression and tdTomato 
reporter expression specifically in 
FoxJ1-expressing ependymal cells 
(Foxj1-Olig2-tdT in Figure 5).  
We made spinal cord injuries in Foxj1-
Olig2-tdT mice and Foxj1-tdT control 
mice. Using a combination of RNA-seq 
and ATAC-seq, we examined 
recombined cells in uninjured spinal 
cords, as well as 1 and 5 days after 
injury. We found  increased chromatin 
accessibility of the Olig2 binding sites 
in cells from Foxj1-Olig2-tdT mice. Furthermore, we found that Sox10 enhancer regions 
gained chromatin accessibility, which was paired with an increased Sox10 expression after 
SCI. This implies that we were able to activate an oligodendrogenesis program by 
introducing Olig2 expression and a SCI. 
After establishing that we could turn on an oligodendrogenesis program by inducing Olig2 
expression in ependymal cells, we asked how that would affect their injury response. We 
analyzed injuries of Foxj1-Olig2-tdT mice and controls 2, 4 and 12 weeks after injury, 
focusing on oligodendrogenesis. We found a sizeable net addition of Sox10 expressing 
oligodendrocyte lineage cells at all time points studied, looking both at single cell RNA 
sequencing data and protein expression in tissue. On average, ~32,000 recombined 
oligodendrocyte lineage cells were found in a lesion 12 weeks after injury. This is 
comparable to the amounts observed after NSC transplantation (Yasuda et al., 2011). In the 
single cell RNA-seq data, we found that the oligodendrogenesis that we induced from 
ependymal cells seemed to recapitulate developmental oligodendrogenesis (for instance, we 
found PDGFRa expression at early time points, and Myrf expression at late time points) 
(Steven A. Goldman & Kuypers, 2015). 
To examine if we could introduce the same oligodendrogenesis program in astrocytes, we 
generated Connexin 30 (Cx30)-Olig2-tdT mice to label and introduce a forced Olig2 
expression in astrocytes. When looking at injuries from Cx30-Olig2-tdT mice, we did not 
find the efficient generation of Olig2-expressing cells that we observed from ependymal cells. 
Figure 5 | Schematic description of the strategy 
used to induce labeling and Olig2 expression in 
ependymal cells.  FoxJ1-tdT denotes the control 
mice (without Olig2 expression), while Foxj1-
Olig2-tdT shows the design of the construct 
turning on Olig2 expression with the labeling of 
Foxj1+ ependymal cells.  
Illustration from Llorens-Bobadilla et al. (2020). 
Used with permission from American Association 
for the Advancement of Science (AAAS). 
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This supports that ependymal cells are specifically permissive to oligodendrogenesis, and 
highlights ependymal cells as an interesting target for stimulating oligodendrogenesis from 
endogenous cells.  
At the latest time point after injury in Foxj1-Olig2-tdT mice, we confirmed the presence of 
myelinating oligodendrocytes generated from ependymal cells with multiple methods. First, 
we found co-localization of tdTomato with myelin basic protein (MBP) that marks 
myelinating oligodendrocytes. Next, we used expansion microscopy on Foxj1-Olig2-tdT 
mice crossed with Thy1-GFP which marks neurofilaments with Green Fluorescent Protein 
(GFP), and visualized axons wrapped by tdTomato expressing ependymal-derived 
oligodendrocytes. Lastly, we confirmed the findings using electron microscopy.  
Using a contusion injury model, we examined if the increased recruitment to the 
oligodendrocyte lineage had an effect on locomotion. We did not detect any difference in 
locomotion measured by Basso Mouse Scale (BMS) or hindlimb scores during 12 weeks after 
injury (Basso et al., 2006). To further understand the potential for recovery of axonal 
conductance induced by activation of the latent oligodendrogenesis program in ependymal 
cells, we performed parallel electrophysiology and optogenetics in vivo. We injected adeno 
associated virus (AAV)-CAG-ChR2-EGFP into the motor cortex in order to label cortical 
neurons and their axons in the corticospinal tract. Optical stimulation was applied rostral to 
the lesion, and recordings were made rostral and caudal to the lesion. We found a higher 
conduction velocity rostral to injuries in Foxj1-Olig2-tdT mice compared to in controls with 
unaltered Olig2 expression, and the conduction velocity correlated with the share of 
myelinated axons in the corticospinal tract.  
The improved axonal conductance observed in Foxj1-Olig2-tdT showed that the 
oligodendrogenesis we induced resulted in a measurable improvement through myelination 
of axons. Despite the large net contribution to the oligodendrocyte lineage observed in tissue, 
we did not see an effect on gross locomotion. This is in line with the literature, since it has 
been reported that manipulation of myelin alone does not affect locomotion (Duncan et al., 
2018). 
In this study we identified ependymal neural stem cells as an interesting target population for 
stimulating endogenous oligodendrogenesis. This could prove an attractive option for 
regenerative treatments, although a greater understanding of the signaling pathways that 
control the process is needed.   
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5.4 PAPER III  
All spinal cord ependymal cells are not the same. The spinal cord ependymal cell population 
contains cells of different shapes, and cells with different protein expression profiles (Bruni & 
Reddy, 1987; Garcia-Ovejero et al., 2013; Meletis et al., 2008; Sabourin et al., 2009). 
Previous work has shown that the ependymal layer encompasses cells that cannot self-renew 
efficiently throughout passages in vitro, while it is known that the ependymal cell population 
contains cells that self-renew efficiently and have stem cell capacities in vitro (Barnabé-
Heider et al., 2010; Fiorelli et al., 2013; Meletis et al., 2008; Sabourin et al., 2009). This 
prompted us to address the question of which population, among the ependymal cells, that 
shows stem cell abilities.  
Troy (Tnfrsf19) is a Wnt target gene that is present in stem cell populations of the 
gastrointestinal tract as well as the SVZ of the brain (Basak et al., 2018; Fafilek et al., 2013; 
Stange et al., 2013). We examined the stem cell capacities of Troy-expressing cells using a 
Troy-CreERT2 mouse line on a Rosa26-tdTomato background. 
Only a minority of all spinal cord ependymal cells (~8%) were recombined in the Troy-
CreERT2 mouse line, and we refer to those as EpA cells. EpA cells are dispersed throughout 
the ependymal layer, although they are more frequently found dorsally.  
We cultured cells from dissociated spinal cords of recombined Troy-CreERT2 mice, and 
found that the primary neurosphere cultures were not enriched for neurospheres generated by 
recombined EpA cells. However, over the passages the recombination rate increased until a 
vast majority of neurospheres originated from the EpA cell population at p2 and onwards. 
Since recombination is seldom complete, this implies that all or nearly all of the cells with in 
vitro NSC capacity in the spinal cord resides in the EpA ependymal cell subpopulation.  
Next, we examined the response of EpA ependymal cells to injury. After SCI, these cells 
started dividing and generated migrating progeny that differentiated into astrocytes and 
oligodendrocytes without the EpA ependymal cell population being depleted in the process. 
This implies that EpA cells are able to self-renew while they generate differentiating progeny, 
although it was not clear from this experiment whether the same cells were able to both self-
renew and generate migrating progeny.  
To better understand the dynamics of the EpA cell reaction to SCI, we crossed the Troy-
CreERT2 mouse line with a Rosa26-Confetti reporter mouse line (Figure 6A). We induced 
recombination to label EpA cells. Recombination led to the expression of any of the four 
fluorescent reporters CFP, GFP, RFP or YFP. The mice were subjected to injury two weeks 
after tamoxifen treatment, and the injured spinal cords were analyzed after two additional 
weeks (Figure 6B). The recombination in the injury sites was low, with an average of less 
than 3 EpA cells per fluorescent reporter in a whole injury site (spanning 1.1 mm, on 
average). The low recombination rate in combination with the stochastic expression of 
fluorescent proteins enabled us to identify and analyze single migrating clones. 
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We found 20 clones containing migrating EpA progeny in 12 spinal cords. Each clone 
contained between 1 and 6 migrating cells, and they spread more in the dorso-lateral direction 
than in the rostro-caudal direction. For the vast majority of clones containing migrating 
progeny, we could identify an EpA ependymal founder cell. This suggested to us that EpA 
cells are able to generate migrating progeny without being consumed in the process, meaning 
they show self-renewal on a single cell level. Among the recombined cells, we found 
evidence for different modes of division. An ependymal cell could give rise to (i) only 
ependymal cells, (ii) ependymal cell(s) + astrocyte(s), and (iii) only astrocytes. In 5 clones 
with mixed progeny (ii), we found only one single ependymal cell and one single migrated 
cell. In those cases, it seems likely that the founding ependymal cell had undergone a single 
asymmetric division.  
Owing to the small ependymal cell contribution towards the oligodendrocyte lineage in 
combination with the early time point at which we conducted the in vivo clonal analysis, we 
did not identify any clone containing oligodendrocyte lineage. Therefore, the question of fate 
restriction in the EpA neural stem cell population remains unanswered. In the SVZ niche, 
there is a functional heterogeneity, and the NSCs that generate oligodendrocytes are typically 
not the same NSCs as those who generate astrocytes and neurons (Ortega et al., 2013). 
To understand the molecular underpinnings of the process leading up to the injury reaction of 
EpA cells, we conducted single cell RNA sequencing on EpA cells from uninjured spinal 
cord, and from spinal cord lesions 3 days after injury – a time point characterized by the 
initial recruitment of ependymal cell progeny, which begin migration from the central canal 
to form astrocytes in the glial scar and a few oligodendrocytes (Sabelström, Stenudd, & 
Frisén, 2013).  
In the scRNAseq data set, we identified three clusters containing ependymal cells, which we 
analyzed further. One cluster, EpA1, contained cells from both uninjured and injured spinal 
cord. These appeared as highly differentiated ependymal cells, and expressed high levels of 
ependymal cell related genes, such as Foxj1, Fam183b, and Rarres2. Another cluster, EpA2, 
encompassed cells from injured spinal cords, with high expression of ribosomal RNA as well 
Figure 6 | Single cell clonal analysis with Troy-CreERT2 on a reporter background. (A) 
Schematic description of the strategy to induce stochastic labeling of EpA cells. (B) Experimental 
timeline. Two weeks after recombination to label EpA cells, dorsal funiculus injuries were made. The 
injuries were analyzed 2 weeks later.  
 
32 
as translation related genes. Lastly, EpA3 contained proliferating cells from injured spinal 
cords. In both EpA2 and EpA3 clusters, ependymal cell markers were downregulated. 
Conversely, genes implicated in differentiation, cell migration and proliferation were 
upregulated. Cells in EpA2 and EpA3 also had increased signaling entropy compared to 
EpA1, which implies a greater multilineage potential, as well as a greater similarity to SVZ 
NSCs (EpA2) and transit amplifying cells (EpA3).  
In summary, we observed highly differentiated EpA ependymal cells downregulate 
ependymal cell markers shortly after SCI. Instead, the EpA cells upregulated genes that 
suggest a transition towards a more stem cell-like state after injury. They expressed more 
ribosomal genes, as well other protein synthesis related genes, which is reminiscent of the 
changes in mRNA expression observed when quiescent NSCs in the SVZ are activated 
(Basak et al., 2018; Llorens-Bobadilla et al., 2015).  
The process in which EpA ependymal cells revert from a highly differentiated cell to one 
with stem cell qualities carries similarity to that of local astrocytes in the striatum 
transitioning to a stem cell-state after striatal stroke or Notch signaling depletion (J. 
Magnusson et al., 2014; J. P. Magnusson et al., 2020). 
In the EpA ependymal cell subpopulation, we have identified a small group of ependymal 
cells that harbor much, if not all, of the in vitro stem cell capacity of the adult spinal cord. 
They behave distinctly different from two previously described ependymal cell subgroups 
(Fiorelli et al., 2013; Sabourin et al., 2009), which both expand in vitro but lack ability to 










6 CONCLUSIONS AND PERSPECTIVES  
This section will focus on our conclusions from the work presented in this thesis, and future 
perspectives relating to the thesis work. Specifically, we found that: 
1. Ependymal cells can limit secondary tissue damage and reduce neuronal loss after 
SCI 
2. We can activate a latent oligodendrogenesis program in ependymal cells, and the 
newly formed oligodendrocytes myelinate nerves and restore conductance after SCI 
3. The EpA ependymal cell subtype harbors nearly all in vitro stem cell potential in the 
adult spinal cord. Upon injury, highly differentiated EpA ependymal cells revert to a 
stem cell-like state.  
The astrocytic component of the glial scar has both beneficial and detrimental effects on the 
pathological processes after SCI. In paper I, we showed that the ependymal cell response to 
SCI is beneficial for limiting lesion size and neuronal loss. Similarly, work by other research 
groups have shown that different parts of the astrocytic scar play different roles in recovery 
(Herrmann et al., 2008; Okada et al., 2006; Wanner et al., 2013). However, the source of the 
astrocytes manipulated in these studies is unknown since they used genes present in both 
ependymal progeny and astrocytes to drive the transgene expression. An increased 
understanding of whether the heterogeneity observed within the glial scar is tied to lineage or 
to location in the scar will be important to device effective and specific treatments targeting 
the intended part of the glial scar. An inducible and targeted reduction of the scar component 
from astrocytes (for instance crossing a CreERT2 line that targets resident astrocytes, Cx30-
CreERT2, with a Rasless mouse line to block their proliferation) could bring clarity on the 
contribution of different scar-forming populations.  
In paper I, we learned that the physiological amount of progeny formed by ependymal cells 
after injury renders a more favorable outcome compared to when we blocked the generation 
of the ependymal-derived scar component. However, this experiment did not answer the 
question of whether the outcome would be better if we had an even larger contribution of 
ependymal-derived astrocytes to the scar. In paper II, we generated more ependymal-derived 
astrocytes in mice with forced Olig2 expression compared to controls. Unfortunately, it is 
difficult to draw any conclusion on the effects on this increase in astrocyte numbers, since the 
addition of new oligodendrocyte lineage cells is far greater. Finding the amount of 
ependymal-derived astrocytes and other scar cell types that is associated with the most 
favorable outcome will be useful to learn what we can and want to achieve when 
manipulating scar-forming cell populations.  
In paper III, we showed that most of (if not all) the in vitro NSC capacity of the adult spinal 
cord is harbored by the EpA ependymal cell subpopulation. An open question is how large a 
share of the in vivo response they account for. To improve our understanding of the EpA 
ependymal cells relative contribution to the ependymal cell response to spinal cord injury, an 
important aspect to understand would be the long-term functional role of the EpA injury 
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reaction. Examining the long-term consequences of selectively blocking the injury response 
by EpA ependymal cells with a similar methodology as we employed in Paper I could 
provide an answer to this question.  
In paper III, we found that ependymal cells are activated upon injury to attain a more stem 
cell-like state. An understanding of the signals that initiate the cascade of EpA cell activation 
upon injury will be essential to control their activation. With the importance of Stat3 for the 
recruitment of a scar component residing where ependymal cell progeny resides in the scar, 
the JAK/STAT pathway is an interesting potential target to examine.  
We identified a latent oligodendrogenesis program in ependymal cells, and activated it by 
forced Olig2 expression combined with SCI. However, no oligodendrocyte gene expression 
was observed without an injury, not even a year after Olig2 induction. This is intriguing in 
the context of Paper III, where we see that EpA ependymal cells revert to a stem cell-like 
state with a larger multipotent potential within days after injury. Perhaps this process is 
required to allow the fate switch of ependymal progeny induced in Paper II.  
While increasing oligodendrogenesis by ependymal cells appears attractive, the method 
employed to activate the oligodendrogenesis program in ependymal cells in paper II is an 
unlikely candidate for translation to human application. To translate these findings and 
circumvent the risks associated with the overexpression of a transcription factor, it will be 
important to address outstanding questions regarding the signaling pathways that regulate the 
fate choices of ependymal cell progeny. 
To assess the feasibility of translating the results in Paper II and other findings from 
modulating stem cell behaviors to human use, it will be important to learn more about the 
differences between mouse and human ependymal cells. To this end, repeating the 
experiment with combined RNA-seq and ATAC-seq employed in Paper II on human spinal 
cord cells could give an interesting perspective on the similarities between ependymal cells in 
humans and mice.  
Through the work behind Paper II, we learned that we can manipulate the fate of spinal cord 
ependymal cell progeny towards the oligodendrocyte lineage to produce >30.000 new 
oligodendrocyte lineage cells after SCI.   
NSC transplantation can improve locomotor function after spinal cord injury, and it has been 
reported that the effect requires the development of myelinating oligodendrocytes (Yasuda et 
al., 2011). In contrast, a recent study showed that locomotor recovery after SCI is not 
dependent on remyelination (Duncan et al., 2018). This is in line with our results, as we did 
not measure any improvement in locomotor recovery.  
In a recent study, the authors stimulated axonal regrowth through spinal cord lesions using a 
growth factor cocktail. They showed more than a 100-fold increase in axonal regrowth, but 
failed to show any improvement in locomotion (Anderson et al., 2018). Newly regenerated 
axons are frequently not myelinated (Alto et al., 2009), and improving their conduction 
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velocity can promote functional recovery (Bei et al., 2017). Together, these results point 
towards a need for combinatorial treatment, where multiple processes are modulated together, 
for instance by promoting axonal regrowth and oligodendrogenesis from endogenous neural 
stem cells in parallel.  
With the research presented in this thesis, we have laid some groundwork that is necessary in 
order to utilize endogenous stem cells for treating spinal cord injury. We have learnt about the 
functions of the ependymal cell response to spinal cord injury, about the plasticity within the 
ependymal cell population, and about the identity of ependymal cells harboring stem cell 
potential, as well as their activation after injury. We have also discussed some challenges 
ahead, and reaching the end of this doctoral thesis, I am excited about the discoveries that are 
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